Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

MVP treatment is effective and safe for recurrent breast cancer.

Baricitinib works better than methotrexate for severe alopecia areata.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

The committee decided not to approve the drug due to low effectiveness and high risks.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

A hospital outbreak of catheter infections in calves was caused by a bacteria from a beef herd, leading to longer hospital stays, more drug use, and calf deaths.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Skin reactions from cancer treatments might predict how well the treatments work.

JAK inhibitors may help improve symptoms in adults with APECED.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.